Drug intelligence / Profile preview

Kechuan Shun Wan

Development stage: Unknown
Lead developer: Guangzhou Chen Li Ji Pharmaceutical
Administration: Oral

Overview

Kechuan Shun Wan is a traditional Chinese medicine (TCM) oral herbal formulation developed and manufactured by Chen Li Ji (Guangzhou Baiyunshan Chen Li Ji Pharmaceutical). It is an approved and marketed product in China, categorized under respiratory and digestive medications. The formulation is primarily indicated for the treatment of respiratory conditions such as chronic bronchitis, asthma, and persistent cough. Its therapeutic actions are traditionally described as ventilating the lungs, resolving phlegm, and relieving cough and breathlessness. As a complex herbal formulation, it exerts its effects through the synergistic interaction of multiple botanical constituents rather than a single molecular target.

Brand names: Chen Li Ji咳喘顺丸
Other names: Kechuan ShunwanKe Chuan Shun Wan

Beyond the preview

Go deeper on Kechuan Shun Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kechuan Shun Wan.

Explore the full profile